PD 1 AND PD L1 INHIBITOR MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

PD-1 and PD-L1 Inhibitor Market, By Type of Inhibitor (PD-1 Inhibitors, PD-L1 Inhibitors), By Cancer Type (Kidney, Melanoma, Bladder, Non-small Cell Lung Cancer, Liver, Head & Neck, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 03 Apr, 2026
Code: CMI173
Page number: 169
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026-2033

Table of Contents (Version-2026):

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Type of Inhibitor
  - Market Snapshot, By Cancer Type
  - Market Snapshot, By Distribution Channel
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Rise in incidence/prevalence of cancer
  - High cost of cancer treatment
  - Rise in research and development activities
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Global PD-1 and PD-L1 Inhibitor Market, By Type of Inhibitor, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- PD-1 Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- PD-L1 Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Global PD-1 and PD-L1 Inhibitor Market, By Cancer Type, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Kidney
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Melanoma
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Bladder
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Non-small Cell Lung Cancer
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Liver
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Head & Neck
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Global PD-1 and PD-L1 Inhibitor Market, By Distribution Channel, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
Global PD-1 and PD-L1 Inhibitor Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2021 – 2033
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Inhibitor, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Inhibitor, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Inhibitor, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Inhibitor, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Inhibitor, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Bn)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type of Inhibitor, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- AstraZeneca PLC
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Gilead Sciences Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Sanofi AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- F. Hoffmann-La Roche AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Merck & Co.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Regeneron Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- GSK plc
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Ono Pharmaceutical Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BeiGene LTD
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now